Composite scaffold provides a cell delivery platform for cardiovascular repair

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Cardiovascular Research

Background:

• Cell engraftment, survival, and function are crucial for effective heart repair.
• Existing methods for cardiac repair often face challenges in cell retention and integration.

Purpose of the Study:

• To develop and evaluate a tissue engineering platform for delivering human mesenchymal progenitor cells (MPCs) using a biological composite scaffold for cardiac repair.
• To assess the impact of MPC delivery via the scaffold on vascularization and cardiac function in a rat model of myocardial infarction.

Main Methods:

• Decellularization of human myocardium to create a biological scaffold preserving extracellular matrix and mechanical properties.
• Construction of a cell-matrix composite using fibrin hydrogel with suspended MPCs on decellularized myocardium.
• In vitro characterization of MPCs, including assessment of myogenic and vasculogenic potential after TGF-β conditioning.
• Implantation of the composite scaffold in a nude rat model of cardiac infarction and subsequent analysis of vascular network formation and cardiac function via echocardiography.

Main Results:

• Preconditioned MPCs delivered via the composite scaffold significantly enhanced vascular network formation in the infarct bed.
• Mechanisms involved paracrine factor secretion (e.g., SDF-1) and MPC migration into ischemic, but not normal, myocardium.
• Echocardiography revealed recovery of left ventricular systolic dimensions and contractility.

Conclusions:

• The developed tissue engineering platform effectively delivers MPCs, promoting vascularization and functional recovery after cardiac infarction.
• This adaptable platform shows promise for delivering various reparative cells and advancing quantitative studies in heart repair research.